LifeVantage Co. (LFVN) to Issue Quarterly Dividend of $0.04 on December 16th

LifeVantage Co. (NASDAQ:LFVN) declared a quarterly dividend on Friday, October 25th,Zacks Dividends reports. Investors of record on Monday, December 2nd will be paid a dividend of 0.04 per share on Monday, December 16th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Monday, December 2nd.

LifeVantage has a payout ratio of 21.3% meaning its dividend is sufficiently covered by earnings.

LifeVantage Stock Up 1.5 %

LFVN opened at $14.61 on Friday. LifeVantage has a twelve month low of $5.22 and a twelve month high of $15.15. The company’s 50-day moving average price is $12.89 and its two-hundred day moving average price is $9.46. The stock has a market cap of $182.92 million, a price-to-earnings ratio of 45.66 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 EPS for the quarter, meeting the consensus estimate of $0.15. The business had revenue of $47.21 million for the quarter. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.